References
- Drummond M. Basic types of economic evaluation. In: Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, New York, NY, USA, 7–27 (2005).
- Office of Technology Assessment Advisory Committee. Development of Medical Technology: Opportunities for Assessment. United States of America Congress, Health Program Advisory Commitee, Washington, DC, USA (1976).
- Harris A, Buxton M, O’Brien B et al. Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries. Expert Rev. Pharmacoeconomics Outcomes Res.1(1), 7–12 (2001).
- Taylor RS, Drummond MF, Salkeld G et al. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ329(7472), 972–975 (2004).
- Hjelmgren J, Berggren F, Andersson F. Health economic guidelines – similarities, differences and some implications. Value Health4(3), 225–250, (2001).
- Kanavos P, Trueman P, Bosilevac A. Can economic evaluation guidelines improve efficiency in resource allocation?. The cases of Portugal, The Netherlands, Finland, and the United Kingdom. Int. J. Technol. Assess. Health Care16(4), 1179–1192 (2000).
- McGuire A, Morris S, Raikou M. Where are the economic guidelines coming from?. Int. J. Technol. Assess. Health Care16(4), 976–986 (2000).
- Walker D. Cost and cost–effectiveness guidelines: which ones to use?. Health Policy Plan16(1), 113–121 (2001).
- Iglesias CP, Drummond MF, Rovira J. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. Int. J. Technol. Assess Health Care21(1), 1–14 (2005).
- Neto G. Utilizaçao de diretrizes nacionais e internacionais para execuçao da avaliaçao de tecnologias em saúde. In: Avaliaçao de Tecnologias em Saúde. Nita M (Ed.). Artmed, Porto Alegre, Brazil, 506–529 (2010).
- Bertozzi S, Valencia Mendoza A, Hernández Garduño C et al.Guía Para la Conducción de Estudios de Evaluación Económica Para la Actualización del Cuadro Básico de Insumos del Sector Salud en México. Instituto Nacional de Salud Pública, Cuernavace, Mexico (2008).
- Banta D, Almeida RT. The development of health technology assessment in Brazil. Int. J. Technol. Assess Health Care25(Suppl. 1), 255–259 (2009).
- Lemgruber A. The role of HTA in the price regulation of new drugs: the Brazilian experience. Presented at: 4th International Symposium of Evidence-Based Health Care. Krakow, Poland, December 7–8 (2009).
- Carrasquilla Gutiérrez G. Implementing pharmacoeconomic guidelines in evidence-based decision making in Latin America: lessons learned?. Presented at: 2nd ISPOR Latin American Meeting. Rio de Janeiro, Brazil, September 10–12 (2009).
- Gomez-Dantes O, Frenk J. Health technology assessment in Mexico. Int. J. Technol. Assess Health Care25(Suppl. 1), 270–275 (2009).
- Mauskopf JA, Sullivan SD, Annemans L et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health10(5), 336–347 (2007).
- Drummond MF, Schwartz JS, Jonsson B et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int. J. Technol. Assess Health Care24(3), 244–258 (2008).
- Rubinstein A, Fernández J, Gianneo O et al.Definition of Coverage Policies in the Context of Health Care Reform in Uruguay: Description of the Process and First Results. Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina (2008).
Websites
- Country-specific pharmacoeconomic guidelines. International Society for Pharmacoeconomics and Outcomes Research (2009) www.ispor.org/peguidelines/index.asp
- Gálvez González A. Guía Metodológica Para la Evaluación Económica en Salud: Cuba 2003. Ministerio de Salud Pública, Escuela Nacional de Salud Pública, Cuba (2003) www.ispor.org/peguidelines/source/MethodologicalGuidelinesfor HealthEconomicEvaluationsinCuba.pdf
- Carrasquilla Gutierrez G. Guía Metodológica para la Elaboración de Guías de Práctica Clínica Basadas en la Evidencia, de Evaluaciones Económicas y de Evaluación del Impacto de la Implementación de las Guías en el POS y en la Unidad de Pago por Capitación del Sistema General de Seguridad Social en Salud Colombiano. Ministerio de la Protección Social Colciencias, Colombia (2008) www.pos.gov.co/Documents/GUIA%20METODOL%C3%93GICA%2023%2011%2009-1.pdf
- Estudos de avaliaçao econômica de tecnologias em saúde. Normas e Manuais Técnicos. Ministerio da Saúde, Brasil (2009) http://bvsms.saude.gov.br/bvs/publicacoes/avaliacao_economica_tecnologias_saude_2009.pdf
- Healthcare in Cuba. Wikipedia, The Free Encyclopediahttp://en.wikipedia.org/wiki/Healthcare_in_Cuba (2010).
- Alfonso R, Augustovski F, Lemgruber A et al. Pharmacoeconomics and outcomes research in Latin America: Argentina, Brazil, Chile, Colombia, and Mexico. ISPOR Connections (2008) www.ispor.org/News/articles/Oct08/LatinAmericaPE.asp
- Ley General de Salud (2007) www.diputados.gob.mx/LeyesBiblio/pdf/142.pdf
- Elaboração de diretrizes metodológicas do Ministério da Saúde para pareceres técnico-científicos, revisões sistemáticas e estudos de avaliação económica. Ministério da Saúde. Secretaria de Ciência, Tecnología e Insumos Estratégicos (2007) http://portal.saude.gov.br/portal/arquivos/doc/documentodiretrizesmetodologicas.pdf
- Pichon-Riviére A. Application of the Key Principles to HTA activities in Latin America. 6th HTAI Annual Meeting. Parallel Panel Session B, Singapore (2009) www.htai2009.org/slides/Plenaries and Breakout Sessions/B1 - HTA for Resource Allocation Decisions-Are Key Principles Re/Andres Pichon-RIVIERE.pdf
- Guía Para la Elaboración de Informes de Evaluación de Tecnologías Sanitarias. Mercosur (2008) www.saludinvestiga.org.ar/pdf/resoluciones/Res-52-08_ES_GuiaElaboInfTecnoSanit.pdf